RMC5127
Product Specifications
CAS Number
3056146-38-1
Target
Apoptosis|||Kras|||Ras|||Kras
Related Pathways
GPCR/G Protein|||MAPK|||Apoptosis
Purity
0.9754
Bioactivity
RMC5127 is an orally available, mutation-selective RAS G12V inhibitor exhibiting central nervous system (CNS) and brain permeability. It suppresses the RAS pathway and induces apoptosis in KRAS G12V mutant cancer cells, demonstrating antitumour activity.
Smiles
C[C@H](OC)C(N=C1)=[C@@]([C@@]2=C(CC(C)(C)COC([C@H]3NN(C([C@@H](NC([C@H]4OC[C@@H]4C)=O)[C@H]5N6CC7(COC7)C6)=O)C8CC3C8)=O)C9=C(C=CC(C%10=CSC5=N%10)=C9)N2CCOC%11CCOCC%11)C=C1N%12CCN(C%13CC%13)CC%12
Molecular Formula
C57H75N9O9S
Molecular Weight
1062.32
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/311084198021709825/T204085
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS964954-01 0.02 mg (E-Coli)
Recombinant Rat Submandibular glandular kallikrein-9 (Klk9)
Ask
View Details